GLP-2 Teduglutide
33-AA analog of native human GLP-2
In Stock — Lot ADV-G2-0871 · COA published
View COA →
$120.00 per 10 mg vial
≥99% HPLCThird-Party TestedCOA Per LotMade in USA
Ships in 24h · Cold-chain guidance included · Batch-matched documentation
| Compound | Teduglutide — GLP-2 receptor agonist |
|---|---|
| Structure | 33-AA analog of native human GLP-2 with Gly→Ala substitution at position 2 for DPP-4 resistance |
| Molecular Weight | ~3900 Da |
| Form | Lyophilized powder, sealed vial |
| Purity | ≥99% by HPLC; identity confirmed by MS |
| Storage | −20 °C lyophilized; 2–8 °C after reconstitution; avoid freeze–thaw |
| Solubility | Sterile / bacteriostatic water |
| Intended Use | In-vitro and preclinical laboratory research only |
Research Areas
Investigated in intestinal epithelial growth and repair models, gut-barrier and mucosal integrity assays, villus-length and crypt-depth studies, and short-bowel–related preclinical research. GLP-2R-mediated crypt-cell proliferation and apoptosis-inhibition pathways are standard study endpoints.
Research Use Only
This compound is a chemical supplied strictly for in-vitro laboratory research. It is not a drug, supplement, or cosmetic, is not FDA-evaluated, and is not for human or veterinary consumption. Not for diagnostic or therapeutic use.
